2020 M&A Annual Review

MORRISON & FOERSTER 2020 M&A ANNUAL REVIEW 11 [W]e expect that [the merger] will provide Adicet with the resources to rapidly accelerate the development of its unique product candidates based on this platform and leverage our cGMP manufacturing process to create best-in-class therapies for patients in need. Anil Singhal, Ph.D., President and CEO, Adicet Bio